Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olwen Hahn

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Hematology/Oncology Clinics of North America|April 19, 2005
Novel therapies in lung cancerOlwen Hahn, Ravi Salgia
Anti-Cancer Agents in Medicinal Chemistry|November 30, 2007
Non-receptor tyrosine kinase inhibitors in lung cancerOlwen Hahn, Ravi Salgia
Current Opinion in Oncology|September 22, 2006
SorafenibOlwen Hahn, Walter Stadler
Journal of Clinical Trials|September 19, 2024
Impact of the COVID-19 Pandemic on Cancer Clinical Trials: Alliance for Clinical Trials in Oncology Experience (Alliance A152022)Rebecca A Snyder, Shauna L Hillman, Veronique Marcotte, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 9, 2024
Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancerEmily Ly, Frederick M Howard, Nan Chen, et al.
Breast Cancer Research and Treatment|April 29, 2023
The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancerElizabeth Terman, Jori Sheade, Fangyuan Zhao, et al.
Research Square|March 30, 2023
The Impact of Race and Age on Response to Neoadjuvant Therapy and Long-Term Outcomes in Black and White Women with Early-Stage Breast CancerElizabeth Terman, Jori Sheade, Fangyuan Zhao, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 14, 2024
Retrospective evaluation of adjuvant capecitabine dosing patterns in triple negative breast cancerKun Lin, Elena Michaels, Eric Polley, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 9, 2015
Medical Student Knowledge of Oncology and Related Disciplines: a Targeted Needs AssessmentJonathan Oskvarek, Steve Braunstein, Jeanne Farnan, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2018
Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance)James J Urbanic, Xiaofei Wang, Jeffrey A Bogart, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Hematology/Oncology Clinics of North America|April 19, 2005
Novel therapies in lung cancerOlwen Hahn, Ravi Salgia
Anti-Cancer Agents in Medicinal Chemistry|November 30, 2007
Non-receptor tyrosine kinase inhibitors in lung cancerOlwen Hahn, Ravi Salgia
Current Opinion in Oncology|September 22, 2006
SorafenibOlwen Hahn, Walter Stadler
Journal of Clinical Trials|September 19, 2024
Impact of the COVID-19 Pandemic on Cancer Clinical Trials: Alliance for Clinical Trials in Oncology Experience (Alliance A152022)Rebecca A Snyder, Shauna L Hillman, Veronique Marcotte, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 9, 2024
Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancerEmily Ly, Frederick M Howard, Nan Chen, et al.
Breast Cancer Research and Treatment|April 29, 2023
The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancerElizabeth Terman, Jori Sheade, Fangyuan Zhao, et al.
Research Square|March 30, 2023
The Impact of Race and Age on Response to Neoadjuvant Therapy and Long-Term Outcomes in Black and White Women with Early-Stage Breast CancerElizabeth Terman, Jori Sheade, Fangyuan Zhao, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 14, 2024
Retrospective evaluation of adjuvant capecitabine dosing patterns in triple negative breast cancerKun Lin, Elena Michaels, Eric Polley, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 9, 2015
Medical Student Knowledge of Oncology and Related Disciplines: a Targeted Needs AssessmentJonathan Oskvarek, Steve Braunstein, Jeanne Farnan, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2018
Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance)James J Urbanic, Xiaofei Wang, Jeffrey A Bogart, et al.
Pageof 4